Response

Response

Weitere Versionen anzeigen (2)

Bibliographische Detailangaben
Hauptverfasser:	Bafadhel, M, Brightling, C, Siddiqui, S
Format:	Journal article
Sprache:	English
Veröffentlicht:	2011

Ähnliche Einträge

Response
von: Bafadhel, M, et al.
Veröffentlicht: (2011)

Response
von: Bafadhel, M, et al.
Veröffentlicht: (2011)

Inhaled glucocorticoids and COPD exacerbations.
von: Brightling, C, et al.
Veröffentlicht: (2015)

Characterising non-eosinophilic COPD
von: Hambleton, K, et al.
Veröffentlicht: (2015)

Free-living Haemophilus Influenzae is associated with increased pulmonary inflammation
von: Thulborn, S, et al.
Veröffentlicht: (2015)

The role of CT scanning in multidimensional phenotyping of COPD.
von: Bafadhel, M, et al.
Veröffentlicht: (2011)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial.
von: Siva, R, et al.
Veröffentlicht: (2014)

Neutrophil elastase as a biomarker for bacterial infection in COPD
von: Thulborn, S, et al.
Veröffentlicht: (2019)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
von: Bafadhel, M, et al.
Veröffentlicht: (2014)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
von: Siva R, et al.
Veröffentlicht: (2014-02-01)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
von: Shrimanker, R, et al.
Veröffentlicht: (2017)

Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD.
von: Thulborn, S, et al.
Veröffentlicht: (2017)

Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
von: Bafadhel, M, et al.
Veröffentlicht: (2011)

Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations.
von: Barker, B, et al.
Veröffentlicht: (2015)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
von: Eltboli, O, et al.
Veröffentlicht: (2014)

Routine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence.
von: Pashley, C, et al.
Veröffentlicht: (2012)

Effect of corticosteroids on epithelial cell response to non-typeable haemophilus influenzae
von: Cane, J, et al.
Veröffentlicht: (2016)

Airways Disease: Phenotyping Heterogeneity Using Measures of Airway Inflammation
von: Siddiqui Salman, et al.
Veröffentlicht: (2007-06-01)

Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD.
von: Doe, C, et al.
Veröffentlicht: (2010)

Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD
von: Thulborn SJ, et al.
Veröffentlicht: (2017-04-01)

Late breaking abstract - Resistomics of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of antimicrobial-resistance-encoding genes
von: Ramsheh, M, et al.
Veröffentlicht: (2018)

S45 Evaluating the sensitivity and specificity of active neutrophil elastase as a biomarker for bacterial infection in subjects with copd
von: Thulborn, SJ, et al.
Veröffentlicht: (2016)

Prednisolone response in patients with COPD.
von: Pavord, I, et al.
Veröffentlicht: (2004)

Biomarkers predicting response to corticosteroid therapy in asthma.
von: Brightling, C, et al.
Veröffentlicht: (2005)

Modelling the effect of gravity on inert-gas washout outputs
von: Foy, B, et al.
Veröffentlicht: (2018)

Detection of cell-dissociated non-typeable haemophilus influenzae in the airways of patients with chronic obstructive pulmonary disease
von: Thulborn, SJ, et al.
Veröffentlicht: (2020)

Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function
von: Bafadhel M, et al.
Veröffentlicht: (2015-06-01)

Detection of Cell-Dissociated Non-Typeable Haemophilus influenzae in the Airways of Patients with Chronic Obstructive Pulmonary Disease
von: Thulborn SJ, et al.
Veröffentlicht: (2020-06-01)

Cell-dissociated haemophilus influenzae and bacteria-associated inflammatory mediators in the airways of patients with chronic obstructive pulmonary disease
von: Thulborn, SJ, et al.
Veröffentlicht: (2017)

COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition.
von: Saha, S, et al.
Veröffentlicht: (2006)

Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.
von: Brightling, C, et al.
Veröffentlicht: (2014)

Body mass and fat mass in refractory asthma: an observational 1 year follow-up study.
von: Bafadhel, M, et al.
Veröffentlicht: (2010)

Proning reduces ventilation heterogeneity in patients with elevated BMI: implications for COVID-19 pneumonia management?
von: Brody H. Foy, et al.
Veröffentlicht: (2020-07-01)

Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.
von: Bafadhel, M, et al.
Veröffentlicht: (2012)

Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD.
von: Bafadhel, M, et al.
Veröffentlicht: (2009)

Symptomatic COPD: is it time for triple therapy?
von: Bafadhel, M
Veröffentlicht: (2018)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
von: Shrimanker, R, et al.
Veröffentlicht: (2017)

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.
von: Brightling, C, et al.
Veröffentlicht: (2000)

Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease.
von: Barker, B, et al.
Veröffentlicht: (2014)

Biomarkers in COPD
von: Ramakrishnan, S, et al.
Veröffentlicht: (2021)